share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

辉瑞 | 4:持股变动声明-董事 Echevarria Joseph
美股sec公告 ·  04/26 13:24
Moomoo AI 已提取核心信息
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
Joseph Echevarria, a reporting person for Pfizer Inc [PFE], was involved in a transaction on April 25, 2024. The specific details regarding the nature of the transaction, including the number of shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer has not been specified, and there is no information provided on the number of shares held after the action.
辉瑞公司 [PFE] 的举报人约瑟夫·埃切瓦里亚于2024年4月25日参与了一笔交易。公告中没有披露有关交易性质的具体细节,包括股票数量、交易价格和股票总价值。Echevarria与辉瑞的关系尚未具体说明,也没有提供有关行动后持有的股票数量的信息。
辉瑞公司 [PFE] 的举报人约瑟夫·埃切瓦里亚于2024年4月25日参与了一笔交易。公告中没有披露有关交易性质的具体细节,包括股票数量、交易价格和股票总价值。Echevarria与辉瑞的关系尚未具体说明,也没有提供有关行动后持有的股票数量的信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息